News

A few dozen scientists protested the cancelling of their research grants by the US government at a ‘science fair’ staged ...
On Tuesday, scientists held an event organized by House Democrats in which they stood in front of posters outlining their ...
In a lengthy list of vetoes Missouri Gov. Mike Kehoe recently announced, one of those denied included the proposal of ...
ROCHESTER, Minn. (KTTC) – A Winona industrial supply company provided assistance to a Wisconsin high school student’s science ...
Good Dads, Inc. – $1.5 million (out of $2 million): Kehoe vetoed funds earmarked for a healthy marriage and fatherhood initiative delivered by the Springfield nonprofit. The governor kept $500,000 in ...
Fauquier Now reported that Mia Heller received a $500 prize from the Patent and Trademark Office Society, a community of intellectual property professionals, for her second-place finish at Ohio's ...
Lilly Horowitz, a senior, won a First Award of $6,000 last month in the Cellular and Molecular Biology category at the 75th ...
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
TARRYTOWN, N.Y. and WASHINGTON, May 16, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Adam Kovalčík, 19, of Dulovce, ...